Evaluation of Efficacy, Safety, and Cognitive Profile of Amisulpride Per Se and Its Comparison with Olanzapine in Newly Diagnosed Schizophrenic Patients in an 8-Week, Double-Blind, Single-Centre, Prospective Clinical Trial

<table class="table-group" id="tab9"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">Animal names test</td><td align="center">Amisulpride</td><td align="center">Olanzapine</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">Visit 1</td><td align="center">9.06 [1.91]</td><td align="center">8.94 [1.99]</td></tr><tr><td align="left">Visit 2</td><td align="center">13.44 [2.06]</td><td align="center">11.81 [2.26]</td></tr><tr><td align="left">Visit 3</td><td align="center">15.88 [1.71]</td><td align="center">13.72 [2.18]</td></tr><tr><td align="left">Mean change</td><td align="center">6.81 [1.57]</td><td align="center">4.78 [1.64]</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Scores in each visit for animal names test (scores presented as mean number of new words generated [SD] values).

International Scholarly Research Notices

tab9

Table 9

Table 9: Evaluation of Efficacy, Safety, and Cognitive Profile of Amisulpride Per Se and Its Comparison with Olanzapine in Newly Diagnosed Schizophrenic Patients in an 8-Week, Double-Blind, Single-Centre, Prospective Clinical Trial 

Table 9 | Evaluation of Efficacy, Safety, and Cognitive Profile of Amisulpride Per Se and Its Comparison with Olanzapine in Newly Diagnosed Schizophrenic Patients in an 8-Week, Double-Blind, Single-Centre, Prospective Clinical Trial 